PCN19 Effectiveness and Medical Costs of Abiraterone Acetate Versus Docetaxel in First-LINE Treatment of Metastatic Castration-Resistant Prostate Cancer from the French Nationwide Claims Database (SNDS): Camerra Study

Abstract

Authors

N. Thurin M. Rouyer M. Gross-Goupil T. Haaser X. Rébillard M. Soulie F. Messaoudi C. Capone E. Bignon S. Lamarque J. Jové C. Droz-Perroteau N. Moore G. de Pouvourville P. Blin

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×